Financial Snapshot

Revenue
$408.0K
TTM
Gross Margin
94.46%
TTM
Net Earnings
-$51.03M
TTM
Current Assets
Q2 2024
Current Liabilities
Q2 2024
Current Ratio
776.0%
Q2 2024
Total Assets
Q2 2024
Total Liabilities
Q2 2024
Book Value
$48.63M
Q2 2024
Cash
Q2 2024
P/E
-0.9749
Sep 13, 2024 EST
Free Cash Flow
-$40.23M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018
Revenue $2.134M $4.812M $8.193M $10.94M $3.980M $2.390M
YoY Change -55.65% -41.27% -25.11% 174.87% 66.53%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018
Revenue $2.134M $4.812M $8.193M $10.94M $3.980M $2.390M
Cost Of Revenue $41.00K $8.391M $0.00
Gross Profit $2.093M -$3.579M $8.193M
Gross Profit Margin 98.08% -74.38% 100.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018
Selling, General & Admin $28.21M $40.73M $42.42M $13.10M $6.860M $5.430M
YoY Change -30.73% -3.98% 223.73% 91.01% 26.34%
% of Gross Profit 1348.02% 517.73%
Research & Development $40.69M $70.83M $157.6M $89.02M $23.81M $18.39M
YoY Change -42.55% -55.05% 77.03% 273.87% 29.47%
% of Gross Profit 1944.29% 1923.48%
Depreciation & Amortization $770.0K $6.600M $1.600M $800.0K $730.0K $650.0K
YoY Change -88.33% 312.5% 100.0% 9.59% 12.31%
% of Gross Profit 36.79% 19.53%
Operating Expenses $68.91M $111.6M $200.0M $102.1M $30.68M $23.82M
YoY Change -38.23% -44.22% 95.85% 232.86% 28.8%
Operating Profit -$66.82M -$115.1M -$191.8M -$91.18M
YoY Change -41.97% -39.97% 110.36%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018
Interest Expense $50.00K $40.00K $90.00K
YoY Change 25.0% -55.56%
% of Operating Profit
Other Income/Expense, Net $4.808M $2.127M -$220.0K $54.00K -$820.0K $0.00
YoY Change 126.05% -1066.82% -507.41% -106.59%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018
Pretax Income -$62.01M -$113.0M -$192.0M -$91.13M -$27.47M -$21.34M
YoY Change -45.13% -41.15% 110.73% 231.74% 28.73%
Income Tax $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$62.01M -$113.0M -$192.0M -$91.13M -$27.47M -$21.34M
YoY Change -45.13% -41.15% 110.73% 231.74% 28.73%
Net Earnings / Revenue -2905.67% -2348.55% -2343.9% -833.0% -690.2% -892.89%
Basic Earnings Per Share -$34.12 -$4.24 -$8.48
Diluted Earnings Per Share -$34.12 -$4.24 -$8.476M -$3.881M -$1.170M -$908.9K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018
Cash & Short-Term Investments $76.73M $130.2M $232.5M $138.5M $21.60M $6.900M
YoY Change -41.06% -44.01% 67.9% 541.2% 213.04%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $901.0K $2.783M $3.387M $49.80M $700.0K $400.0K
YoY Change -67.62% -17.83% -93.2% 7014.29% 75.0%
Inventory
Prepaid Expenses
Receivables $50.00K $200.0K $1.800M $2.000M
Other Receivables $0.00 $300.0K $0.00 $0.00
Total Short-Term Assets $77.68M $133.3M $236.1M $188.7M $24.10M $9.300M
YoY Change -41.72% -43.55% 25.13% 682.99% 159.14%
Property, Plant & Equipment $15.45M $34.23M $23.44M $9.700M $1.500M $1.800M
YoY Change -54.87% 46.07% 141.6% 546.67% -16.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.542M $1.776M $6.278M $0.00 $100.0K $200.0K
YoY Change -13.18% -71.71% -100.0% -50.0%
Total Long-Term Assets $16.99M $36.01M $29.71M $9.700M $1.600M $2.100M
YoY Change -52.81% 21.19% 206.32% 506.25% -23.81%
Total Assets $94.67M $169.3M $265.8M $198.4M $25.70M $11.40M
YoY Change
Accounts Payable $1.339M $3.768M $5.122M $4.900M $1.600M $1.500M
YoY Change -64.46% -26.43% 4.53% 206.25% 6.67%
Accrued Expenses $7.433M $8.904M $12.90M $10.40M $1.900M $1.500M
YoY Change -16.52% -31.0% 24.08% 447.37% 26.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.772M $12.67M $19.11M $16.00M $4.000M $3.400M
YoY Change -30.78% -33.68% 19.41% 300.0% 17.65%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $16.79M $29.88M $12.75M $0.00 $100.0K $300.0K
YoY Change -43.82% 134.44% -100.0% -66.67%
Total Long-Term Liabilities $16.79M $29.88M $12.75M $0.00 $100.0K $300.0K
YoY Change -43.82% 134.44% -100.0% -66.67%
Total Liabilities $25.56M $42.55M $31.85M $16.00M $4.100M $3.700M
YoY Change -39.94% 33.59% 99.07% 290.24% 10.81%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018
Basic Shares Outstanding 1.818M 26.63M 22.66M
Diluted Shares Outstanding 1.818M 26.63M 22.66M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $49.748 Million

About Talis Biomedical Corp

Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company is headquartered in Chicago, Illinois and currently employs 99 full-time employees. The company went IPO on 2021-02-12. The firm is focused on advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care.

Industry: Laboratory Analytical Instruments Peers: Abbott Laboratories Aspira Women's Health Inc. Conformis Inc Microbot Medical Inc IRIDEX Corp Milestone Scientific Inc Nemaura Medical Inc Scientific Industries Inc Vapotherm Inc